Applicability of the adjusted graded prognostic assessment for lung cancer with brain metastases using molecular markers (Lung‐molGPA) in a Chinese cohort: A retrospective study of multiple institutions

BACKGROUND: In this era of precision medicine, prognostic heterogeneity is an important feature of patients with non‐small cell lung cancer (NSCLC) with brain metastases (BM). This multi‐institutional study is aimed to verify the applicability of the adjusted Lung‐molGPA model for NSCLC with BM in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Tingyou, Zhang, Yu, Zhou, Lin, Deng, Shanshan, Huang, Meijuan, Liu, Yuncong, Liu, Yongmei, Gong, Youlin, Zhu, Jiang, Xue, Jianxin, Bai, Yuju, Ma, Hu, Zhang, Yan, Yu, Min, Li, Yanying, Wang, Yongsheng, Zou, Bingwen, Zhou, Xiaojuan, Xiu, Weigang, Na, Feifei, Xu, Yong, Peng, Feng, Wang, Jin, Lu, You
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724493/
https://www.ncbi.nlm.nih.gov/pubmed/33027555
http://dx.doi.org/10.1002/cam4.3485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724493/
https://www.ncbi.nlm.nih.gov/pubmed/33027555
http://dx.doi.org/10.1002/cam4.3485

Ejemplares similares